YESFYNA Trademark

Trademark Overview

On Thursday, July 30, 2020, a trademark application was filed for YESFYNA with the United States Patent and Trademark Office. The USPTO has given the YESFYNA trademark a serial number of 90083703. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 25, 2024. This trademark is owned by Supernus Pharmaceuticals, Inc.. The YESFYNA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
yesfyna

General Information

Serial Number90083703
Word MarkYESFYNA
Filing DateThursday, July 30, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 29, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSupernus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameSupernus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, March 25, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 25, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 30, 2023SOU EXTENSION 5 GRANTED
Wednesday, August 23, 2023SOU EXTENSION 5 FILED
Wednesday, August 30, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 23, 2023SOU TEAS EXTENSION RECEIVED
Saturday, February 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2023SOU EXTENSION 4 GRANTED
Thursday, February 23, 2023SOU EXTENSION 4 FILED
Thursday, February 23, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 23, 2022SOU EXTENSION 3 GRANTED
Tuesday, August 23, 2022SOU EXTENSION 3 FILED
Tuesday, August 23, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 5, 2022ASSIGNED TO EXAMINER
Friday, February 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 23, 2022SOU EXTENSION 2 GRANTED
Wednesday, February 23, 2022SOU EXTENSION 2 FILED
Wednesday, February 23, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2021SOU EXTENSION 1 GRANTED
Monday, August 23, 2021SOU EXTENSION 1 FILED
Monday, August 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 29, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 9, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 18, 2020ASSIGNED TO EXAMINER
Friday, August 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 3, 2020NEW APPLICATION ENTERED

Related Keywords

yesfyna diseases system nervous disorders neurological peripheral psychiatric central therapeutic preparations